Now arrived for recently graduated dermatologists: the JDD Welcome Kit! The Journal of Drugs in Dermatology (JDD), together with generous sponsors, has sent these curated kits to the newest members…
Read More
Background: The objective of this survey was to obtain feedback and insights from United States dermatology healthcare professionals on their perceptions of sunscreens. Methods: This cross-sectional survey study launched online…
Read More
Join Dr. Zoe Diana Draelos, MD, as she presents data on over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay Dr. Draelos will discuss Xerosis Management…
Read More
Don’t lose platelets to the gel: simple tweaks boost PRP yield from thixotropic systems We are pulling out this must-read article from the vault. This brief report from the November…
Read More
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast's Steroid Stewardship Series,…
Read More
Lessons learned from a challenging lived experience is a terrible thing to waste…which is why we would NEVER do so! In this episode of the JDD Podcast’s Steroid Stewardship Series,…
Read More
Despite millennia of observation and modern understanding of HPV, treatment choices remain trade‑offs between efficacy, speed and tolerability Warts are caused by non‑enveloped double‑stranded DNA human papillomaviruses and, while two‑thirds…
Read More
Representation improving but not solved—Black patients still underrepresented in recent HS trials A review of ClinicalTrials.gov trials for hidradenitis suppurativa initiated between June 2020 and December 2024 identified five trials…
Read More
Case report: IL‑31 receptor blockade markedly reduced neuropathic pruritus and improved quality of life in a 52‑year‑old woman after standard therapies failed Scarring reflects replacement of normal dermis by fibroblast-driven,…
Read More
Navigating the New Dermatology Landscape: Billing, Virtual Care, and the Rise of DermTok In the past several years, managing and running a dermatology practice has changed drastically. These changes have…
Read More
Review places silicone and occlusion as first‑line topical therapy, with retinoids, pressure, corticosteroids and cannabinoids as situational tools amid limited high‑quality evidence Scarring reflects replacement of normal dermis by fibroblast-driven,…
Read More
Efficient history, targeted exam, selective labs and clear shared‑decision plans let dermatologists deliver meaningful vitiligo care in time‑pressed visits In routine practice, non‑segmental vitiligo (NSV) visits can be both brief…
Read More
